Market Cap (In USD)
227.27 Million
Revenue (In USD)
-
Net Income (In USD)
-63.67 Million
Avg. Volume
76.4 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.795-3.455
- PE
- -
- EPS
- -
- Beta Value
- 1.036
- ISIN
- US63909J1088
- CUSIP
- 63909J108
- CIK
- 1808805
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Sujal M. Patel
- Employee Count
- -
- Website
- https://www.nautilus.bio
- Ipo Date
- 2020-08-07
- Details
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
More Stocks
-
ABL
-
GFPT-RGFPT Public Company Limited
GFPT-R
-
PAH3
-
2OYDow Inc.
2OY
-
HENG
-
SMSI
-
FDX
-
300612